Howard Lossing

Howard Lossing started as Chief Operating Officer and now serves as Chief Executive Officer of Cambrooke Therapeutics. Howard has held domestic and international leadership roles in marketing, sales, operations, and executive management with medical foods, packaged goods and start-up technology companies.

Howard previously held numerous leadership positions with Nutricia North America (a subsidiary of Danone) overseeing its severe protein allergy, inborn error of metabolism and ketogenic diet medical food businesses. He also led business strategy, development and acquisitions during his nearly nine-year tenure spanning assignments based in the US, Canada and the United Kingdom.

Prior to Nutricia, Howard was an executive in two successful start-up technology firms and was with Procter & Gamble in several brand management positions in its Health Care and Paper divisions. Howard has a dual bachelor’s degree in Mechanical Engineering and Engineering & Public Policy from Carnegie Mellon University and an MBA from The Fuqua School of Business at Duke University.